These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2185759)

  • 41. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
    al Gohary OM
    Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of the methods of in vitro evaluation of the neutralizing properties of drugs from the antacid group].
    Pawlaczyk J; Kokot Z; Urbowicz G; Ewertowska D
    Acta Pol Pharm; 1989; 46(3):272-9. PubMed ID: 2618772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magaldrate stimulates endogenous prostaglandin E2 synthesis in human gastric mucosa in vitro and in vivo.
    Schmidt C; Baumeister B; Kipnowski J; Miederer SE; Vetter H
    Hepatogastroenterology; 1998; 45(24):2443-6. PubMed ID: 9951941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative study of the antacid effect of some commonly consumed foods for hyperacidity in an artificial stomach model.
    Panda V; Shinde P; Deora J; Gupta P
    Complement Ther Med; 2017 Oct; 34():111-115. PubMed ID: 28917362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [In vitro determination of the neutralizing capacity of antacids].
    Brunner H
    Z Gastroenterol; 1983 Mar; 21 Suppl():22-5. PubMed ID: 6858407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy in vivo of almagate in neutralising histamine-induced acid secretion in a rat re-perfused stomach preparation.
    Llupiá J; Beckett PR; Lumachi B; Roberts DJ
    Arzneimittelforschung; 1984; 34(10A):1370-2. PubMed ID: 6548923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Protective effect of alkalies on ethyl alcohol-damaged gastric mucosa].
    Mach T
    Folia Med Cracov; 1989; 30(3-4):93-101. PubMed ID: 2641941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of antacid on gastric and duodenal bulb acidity.
    Hannibal S; Remvig L; Rune SJ
    Scand J Gastroenterol Suppl; 1980; 58():29-36. PubMed ID: 6929092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat.
    Borella LE; DiJoseph JF; Mir GN
    Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lattice structure antacids and antacid mixtures].
    Miederer SE; Schmidt C
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():130-5. PubMed ID: 3660893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prostaglandin synthesis in stomach and duodenal mucosa of the human: effect of aspirin with and without antacid].
    Stange EF; Preclik G; Gerber K; Fetzer G; Horn H; Schneider A; Ditschuneit H
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():162-5. PubMed ID: 3116776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled-release of antacids from biopolymer microgels under simulated gastric conditions: Impact of bead dimensions, pore size, and alginate/pectin ratio.
    Chen F; Zhang Z; Deng Z; Zhang R; Fan G; Ma D; McClements DJ
    Food Res Int; 2018 Apr; 106():745-751. PubMed ID: 29579983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid.
    Russell RM; Golner BB; Krasinski SD; Sadowski JA; Suter PM; Braun CL
    J Lab Clin Med; 1988 Oct; 112(4):458-63. PubMed ID: 2902178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New aspects of clinical pharmacology of antacids.
    Konturek SJ
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):5-21. PubMed ID: 8260735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the neutralizing capacity in vitro of some typified antacid preparations].
    Pastia A; Caba M; Gafiţanu E; Matei I
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(1):123-5. PubMed ID: 674940
    [No Abstract]   [Full Text] [Related]  

  • 56. Gastric mucosal calcinosis. Calcified aluminum phosphate deposits secondary to aluminum-containing antacids or sucralfate therapy in organ transplant patients.
    Greenson JK; Trinidad SB; Pfeil SA; Brainard JA; McBride PT; Colijn HO; Tesi RJ; Lucas JG
    Am J Surg Pathol; 1993 Jan; 17(1):45-50. PubMed ID: 8447508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Metabolic effects of antacids and interactions with other drugs].
    Gugler R; Musch E
    Z Gastroenterol; 1983 Mar; 21 Suppl():127-33. PubMed ID: 6858404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prolonged effect of an antacid treatment on changes in gastric potential difference induced by aspirin in man].
    Bergmann JF; Simoneau G; Dorf G; Caulin C; Segrestaa JM
    Therapie; 1989; 44(1):39-42. PubMed ID: 2734719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a new antacid, almagate.
    Beneyto JE; Fábregas JL; Moragues J; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1350-4. PubMed ID: 6439224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. If stomach acid helps digest food, how is food digested if you take an antacid after a meal?
    Mayo Clin Health Lett; 2006 Mar; 24(3):8. PubMed ID: 16568551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.